http://www.sciencedaily.com/releases/2011/12/111220172622.htm
ScienceDaily (Dec. 20, 2011) — Patients with systolic hypertension who were treated with the diuretic chlorthalidone for 4.5 years as part of a clinical trial had a significantly lower rate of death and a gain in life expectancy free from cardiovascular death about 20 years later compared to patients who received placebo, according to a study in the December 21 issue of JAMA.
.....
No comments:
Post a Comment